Financial Summary (in thousands, except 'per share' amounts)
Three Months Ended | Twelve Months Ended | ||||||||||
2025 | 2024 | % Change | 2025 | 2024 | % Change | ||||||
Total Revenues | $ 67,519 | $ 50,758 | 33 % | $ 237,262 | $ 187,025 | 27 % | |||||
Gross Profit | $ 15,194 | $ 12,277 | 24 % | $ 59,833 | $ 39,386 | 52 % | |||||
Net Income | $ 3,025 | $ 4,429 | (32) % | $ 30,528 | $ 10,498 | 191 % | |||||
Diluted Income Per Share | $ 0.08 | $ 0.14 | (43) % | $ 0.84 | $ 0.34 | 147 % | |||||
Full-Year and Fourth Quarter 2025 Highlights
- Highest quarterly and annual revenues since 2017.
- Data Analytics achieved its highest-ever quarterly and annual revenue.
- Strategic entry into power services in 2025 sets stage for high-margin, recurring revenue growth in 2026 and beyond.
- Gross profit climbed 24% vs. fourth quarter 2024 and 52% as compared to full year 2024.
- Data Analytics' gross profit accounted for 48% of total Company gross profit during the fourth quarter of 2025, as compared to 8% in the year ago quarter.
- 2025 net income totaled
$30.5 million or$0.84 per diluted share, vs.$0.34 per diluted share in 2024.
Adjusted EBITDA Calculation Modification
The Company's revenue, as reported under generally accepted accounting principles, includes a non-cash reduction related to the amortization of contract assets. Historically, the Company added back this non-cash revenue reduction in its calculation of Adjusted EBITDA.
Beginning with year-end 2025 reporting, the Company has revised its calculation of Adjusted EBITDA and will no longer add back the non-cash amortization of contract assets associated with the ProFrac Agreement in accordance with relevant
The following table presents the Company's Adjusted EBITDA for the quarter and year-end
Three Months Ended | Twelve Months Ended | ||||||||||
2025 | 2024 | % Change | 2025 | 2024 | % Change | ||||||
Adjusted EBITDA (Revised)(1)(2) | $ 8,047 | $ 5,752 | 40 % | $ 32,790 | $ 14,715 | 123 % | |||||
The Company's previously issued 2025 Adjusted EBITDA(3) guidance of
(1) | Represents a non-GAAP financial measure, see the "Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings" table in this release for more information about this measure, including reconciliations to the most comparable GAAP measures. |
(2) | Under the Company's previous methodology of computing Adjusted EBITDA, the Company added back non-cash amortization of contract assets totaling |
(3) | Represents a non-GAAP financial measure, see the "Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings" table in this release for more information about this measure. We are not able to reconcile this forward-looking non-GAAP measure to the most directly comparable GAAP financial measure without unreasonable efforts, as we are unable to predict with a reasonable degree of certainty the impact of certain items that would be expected to impact the GAAP financial measure, including, among other items, certain stock-based compensation costs, interest costs related to fluctuations in borrowings outstanding under the Company's asset based loan and the impact of the revaluation of certain liabilities, which is based upon our future stock price. These items do not impact the non-GAAP financial measure. |
Management Commentary
Chief Executive Officer Dr.
The
Our 2025 results, including 191% growth in net income and a 123% increase in Adjusted EBITDA(1), were achieved safely and efficiently. The best is yet to come as we capitalize on these foundations to drive sustained, profitable expansion."
Fourth Quarter and Full-Year 2025 Financial Results
Revenue:
Segment Revenue Summary (in thousands)
Three Months Ended | Twelve Months Ended | |||||||||||
2025 | 2024 | % Change | 2025 | 2024 | % Change | |||||||
Chemistry Technologies: | ||||||||||||
External Revenues | $ 14,791 | $ 21,071 | (30) % | $ 79,565 | $ 63,214 | 26 % | ||||||
Related Party Revenues | 42,659 | 27,215 | 57 % | 130,221 | 114,947 | 13 % | ||||||
Total | $ 57,450 | $ 48,286 | 19 % | $ 209,786 | $ 178,161 | 18 % | ||||||
Data Analytics: | ||||||||||||
Product Revenues | $ 2,154 | $ 825 | 161 % | $ 7,330 | $ 4,745 | 54 % | ||||||
Service Revenues | 7,915 | 1,647 | 381 % | 20,146 | 4,119 | 389 % | ||||||
Total | $ 10,069 | $ 2,472 | 307 % | $ 27,476 | $ 8,864 | 210 % | ||||||
Gross Profit: The Company generated gross profit of
The increase in fourth quarter 2025 gross profit was partially offset by a
The Company generated gross profit of
Selling, General and Administrative ("SG&A") Expense: SG&A expense totaled
Net Income and EPS:
2026 Guidance
Consistent with 2025 and 2024,
Upcoming Investor Events
Below are some upcoming events where you may get the opportunity to meet with our team:
March 12 th, 2026,9am CT :Flotek 4th Qtr. & FY 2025 Earnings Conference CallMarch 23-24 th, 2026: 38th AnnualROTH Conference (Dana Point, CA )May 26-28 th, 2026:Louisiana Energy Conference 2026 (New Orleans, LA )
For more event details visit our Investor Relations page at https://ir.flotekind.com/events
Conference Call Details
The Company plans to host its earnings conference call on
Participants may access the call through
About
Forward-Looking Statements
Certain statements set forth in this press release constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) regarding
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except share data) | |||
ASSETS | |||
Current assets: | |||
Cash and cash equivalents | $ 5,731 | $ 4,404 | |
Restricted cash | 104 | 102 | |
Accounts receivable, net of allowance for credit losses of | 19,043 | 17,386 | |
Accounts receivable, related party, net of allowance for credit losses of $0 at | 64,204 | 52,370 | |
Inventories, net | 10,629 | 13,303 | |
Other current assets | 3,445 | 2,952 | |
Current contract asset | 7,621 | 5,939 | |
Total current assets | 110,777 | 96,456 | |
Long-term contract asset | 55,115 | 63,105 | |
Property and equipment, net | 20,344 | 6,178 | |
Right-of-use assets | 3,083 | 3,326 | |
Deferred tax assets, net | 29,152 | 51 | |
Other long-term assets | 1,578 | 1,680 | |
TOTAL ASSETS | $ 220,049 | $ 170,796 | |
LIABILITIES AND STOCKHOLDERS' EQUITY | |||
Current liabilities: | |||
Accounts payable | $ 48,317 | $ 38,073 | |
Accrued liabilities | 7,256 | 5,912 | |
Income taxes payable | 258 | 48 | |
Interest payable, related party | 1,008 | — | |
Current portion of operating lease liabilities | 1,251 | 1,486 | |
Current portion of finance lease liabilities | 153 | — | |
Asset-based loan | 3,332 | 4,789 | |
Current portion of long-term debt | — | 60 | |
Total current liabilities | 61,575 | 50,368 | |
Deferred revenue, long-term | — | 14 | |
Note payable - related party | 39,584 | — | |
Long-term operating lease liabilities | 5,608 | 6,514 | |
Long-term finance lease liabilities | 224 | — | |
TOTAL LIABILITIES | 106,991 | 56,896 | |
Commitments and contingencies | |||
Stockholders' equity: | |||
Preferred stock, | — | — | |
Common stock, | 3 | 3 | |
Additional paid-in capital | 434,964 | 464,620 | |
Accumulated other comprehensive income | 96 | 251 | |
Accumulated deficit | (285,780) | (316,308) | |
| (36,225) | (34,666) | |
Total stockholders' equity | 113,058 | 113,900 | |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ 220,049 | $ 170,796 | |
Unaudited Condensed Consolidated Statements of Operations (in thousands, except per share data) | |||||||
Three Months Ended | Twelve Months Ended | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Revenue: | |||||||
Revenue from external customers | $ 17,890 | $ 23,328 | $ 90,436 | $ 71,263 | |||
Revenue from related party | 49,629 | 27,430 | 146,826 | 115,762 | |||
Total revenues | 67,519 | 50,758 | 237,262 | 187,025 | |||
Cost of goods sold | 52,325 | 38,481 | 177,429 | 147,639 | |||
Gross profit | 15,194 | 12,277 | 59,833 | 39,386 | |||
Operating costs and expenses: | |||||||
Selling, general, and administrative | 7,606 | 6,630 | 28,046 | 24,709 | |||
Asset acquisition expenses | — | — | 4,362 | — | |||
Depreciation | 629 | 229 | 1,836 | 891 | |||
Research and development | 463 | 365 | 1,822 | 1,714 | |||
Severance expenses | 508 | — | 530 | — | |||
Gain on sale of property and equipment | — | (90) | (7) | (124) | |||
Total operating costs and expenses | 9,206 | 7,134 | 36,589 | 27,190 | |||
Income from operations | 5,988 | 5,143 | 23,244 | 12,196 | |||
Other income (expense): | |||||||
Interest expense | (1,374) | (253) | (3,937) | (1,095) | |||
Other income (expense), net | 69 | (105) | 348 | 46 | |||
Total other expense | (1,305) | (358) | (3,589) | (1,049) | |||
Income before income taxes | 4,683 | 4,785 | 19,655 | 11,147 | |||
Income tax benefit (expense) | (1,658) | (356) | 10,873 | (649) | |||
Net income | $ 3,025 | $ 4,429 | $ 30,528 | $ 10,498 | |||
Income per common share: | |||||||
Basic | $ 0.08 | $ 0.15 | $ 0.90 | $ 0.36 | |||
Diluted | $ 0.08 | $ 0.14 | $ 0.84 | $ 0.34 | |||
Weighted average common shares: | |||||||
Weighted average common shares used in | 36,023 | 29,642 | 33,903 | 29,534 | |||
Weighted average common shares used in | 38,268 | 31,436 | 36,156 | 30,889 | |||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands) | |||
Twelve Months Ended | |||
2025 | 2024 | ||
Cash flows from operating activities: | |||
Net income | $ 30,528 | $ 10,498 | |
Adjustments to reconcile net income to net cash provided by operating activities: | |||
Change in fair value of contingent consideration | (127) | 71 | |
Amortization of contract assets | 6,308 | 5,612 | |
Depreciation | 1,836 | 891 | |
Amortization of deferred financing costs | 345 | 314 | |
Provision for credit losses, net of recoveries | 603 | 181 | |
Provision for excess and obsolete inventory | 442 | 645 | |
Gain on sale of property and equipment | (7) | (124) | |
Non-cash lease expense | 1,025 | 2,094 | |
Stock compensation expense | 2,300 | 1,366 | |
Deferred income tax (benefit) expense | (11,185) | 249 | |
Changes in current assets and liabilities: | |||
Accounts receivable | (2,260) | (3,880) | |
Accounts receivable, related party | (36,634) | (17,801) | |
Inventories | 3,066 | (1,110) | |
Income tax receivable | (32) | 8 | |
Other assets | (473) | 561 | |
Accounts payable | 10,244 | 6,368 | |
Accrued liabilities | 1,457 | (70) | |
Operating lease liabilities | (1,450) | (2,515) | |
Income taxes payable | 210 | 3 | |
Interest payable, related party | 1,008 | — | |
Net cash provided by operating activities | 7,204 | 3,361 | |
Cash flows from investing activities: | |||
Capital expenditures | (1,984) | (1,940) | |
Proceeds from sale of assets | 7 | 124 | |
Net cash used in investing activities | (1,977) | (1,816) | |
Cash flows from financing activities: | |||
Payments on long term debt | (60) | (179) | |
Proceeds from asset-based loan | 186,950 | 166,950 | |
Payments on asset-based loan | (188,407) | (169,653) | |
Payment of asset-based loan origination costs | (169) | (164) | |
Payment of note payable issuance costs | (480) | — | |
Payment of issuance costs of stock warrants | (653) | — | |
Payments to tax authorities for shares withheld from employees | (1,559) | (162) | |
Proceeds from issuance of stock under Employee Stock Purchase Plan | 155 | 114 | |
Proceeds from issuance of stock from stock option exercises | 576 | — | |
Payments for finance leases | (96) | (22) | |
Net cash used in financing activities | (3,743) | (3,116) | |
Effect of changes in exchange rates on cash and cash equivalents | (155) | 124 | |
Net change in cash and cash equivalents and restricted cash | 1,329 | (1,447) | |
Cash and cash equivalents at the beginning of period | 4,404 | 5,851 | |
Restricted cash at the beginning of period | 102 | 102 | |
Cash and cash equivalents and restricted cash at beginning of period | 4,506 | 5,953 | |
Cash and cash equivalents at end of period | 5,731 | 4,404 | |
Restricted cash at the end of period | 104 | 102 | |
Cash and cash equivalents and restricted cash at end of period | $ 5,835 | $ 4,506 | |
Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings (in thousands) | |||||||
Three Months Ended | Twelve Months Ended | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Net income | $ 3,025 | $ 4,429 | $ 30,528 | $ 10,498 | |||
Interest expense | 1,374 | 253 | 3,937 | 1,095 | |||
Income tax (benefit) expense | 1,658 | 356 | (10,873) | 649 | |||
Depreciation and amortization | 629 | 229 | 1,836 | 891 | |||
EBITDA (Non-GAAP) (1) | $ 6,686 | $ 5,267 | $ 25,428 | $ 13,133 | |||
Stock compensation expense | 594 | 451 | 2,300 | 1,366 | |||
Severance and retirement | 508 | 7 | 575 | 39 | |||
Contingent liability revaluation | — | 117 | (127) | 71 | |||
Gain on disposal of asset | — | (90) | (7) | (124) | |||
Non-Recurring professional fees (2) | 259 | — | 4,621 | 230 | |||
Adjusted EBITDA (Non-GAAP) (1) | $ 8,047 | $ 5,752 | $ 32,790 | $ 14,715 | |||
(1) | Management believes that EBITDA and Adjusted EBITDA for the three and twelve months ended |
(2) | Includes |
View original content to download multimedia:https://www.prnewswire.com/news-releases/flotek-continues-data-driven-growth-trajectory-delivering-strongest-quarterly-revenue-since-2017-302711457.html
SOURCE